Gilead Sciences Updates FY Outlook Following 2Q Results
By Kathryn Hardison Gilead Sciences Inc. raised its full-year guidance on Tuesday for total product sales and adjusted earnings per share, while it cut its...
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global
Like